
Formerly of Harvard Medical School and Beth Israel Deaconess Medical Center, Dr. R. Keith Reeves is currently tenured Professor of Surgery at Duke University, as well as Director of the Division of Innate and Comparative Immunology and Head of Innovation Partnerships in the Center for Human Systems Immunology. He is also currently the Director of the Duke CFAR Developmental Core and Editor-in-Chief of AIDS Research and Human Retroviruses. Over his academic career he has published extensively in the field of NK cell biology, providing some of the most comprehensive analyses of NK cells and innate lymphoid cells, including the first characterization of memory NK cells in any primate species. Dr. Reeves’ research has been supported by NIH for over a decade by individual and consortia grants, and in addition to independent work, he collaborates as part of the HIV Vaccine Trials Network (HVTN) and the BEAT-HIV Martin Delaney HIV Cure Collaboratory. Dr. Reeves has also served on multiple standing NIH study sections (HIV Immunopathogenesis and Vaccine Development), as well as on standing and ad hoc grant review committees for amfAR, the United States-Israel Binational Science Foundation, the UK Medical Research Council and California Institute of Regenerative Medicine, among others. Considered a global expert in NK cell biology, Dr. Reeves’ group continues to focus on cutting edge approaches to harness NK cells in the context of vaccines and antiviral therapeutics for HIV, CMV, HCV, influenza and SARSCoV2.
Education and Training
- Ph.D., University of Alabama Birmingham, 2007
- B.S., Mississippi State University, 2002
In the News
- Duke Surgery Ranks #1 in NIH FundingFebruary 11, 2022
- R. Keith Reeves, PhD, Joins Duke Surgery's Center of Human Systems ImmunologySeptember 23, 2021
- Future Vaccines Depend on Test Subjects in Short Supply: MonkeysFebruary 23, 2021
- America Is Running Low on a Crucial Resource for COVID-19 VaccinesAugust 31, 2020
- Natural killers are coming for Covid-19 and the therapy, experts say, could make things worseApril 9, 2020
- Natural Killers Adapt :: The Foundation for AIDS ResearchOctober 16, 2015
- Are Early Immune Defenses Helping HIV Flourish?July 15, 2015
Selected Grants
- Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
- Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
- NK cell mobilization as a pathogenic etiology of SARSCoV2 gastrointestinal disease
- Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
- Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir
- Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
- Microbial and innate immune mechanisms of oral inflammation during SIV infection
- BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
- Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection